Kate Perkins, owner of “Cancer Rehabilitation and Lymphatic Solutions” and a long-time user of the M6 and M8 device, has no doubts: MLS® Laser Therapy has proven effective in reducing symptoms related to the effects of anti-tumour therapies and lymphedema in patients.
How and why did you decide to incorporate laser therapy into your practice?
I'm cancer rehabilitation and lymphatic specialist, occupational therapist, and laser has been in my clinic since 2017 to treat the side effects of cancer treatment and lymphedema symptoms. I introduced MLS into my practice in 2021.
How did you learn about MLS® Laser Therapy?
So at one of our trade shows, lymphology trade shows back in 2021, I met Doctor Catherine Norton, who had a stand with an MLS laser. And as soon as I knew the benefits of the MLS® laser I was keen to get one into my practice.
What led you to try laser therapy for such a "delicate" application?
The side effects of cancer treatments and lymphedema can be quite painful, so delivering a treatment that is not invasive is crucial to my practice.
What benefits have you seen in your patients after laser treatments?
Some of the side effects of cancer treatment can include post operative healing, radiation fibrosis, the development of lymphedema symptoms and chemo induced peripheral neuropathy. So I have observed and my patients have experienced some incredible outcomes in reduction in symptoms and their recovery from treatment is so fast and discharge of care is fast, so they are happy to get back to doing their normal day-to-day activities faster. It is quite incredible.
And what is their feedback?
Their feedback is wow, this is amazing, and they feel so much better. And that is common. I get to see that every day and having that reaction every day makes my job satisfaction, so much nicer every day.
Please describe ASAlaser with 3 adjectives.
Powerful, sleek and revolutionary.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.